organophosphonates has been researched along with 15-deoxyprostaglandin j2 in 1 studies
Studies (organophosphonates) | Trials (organophosphonates) | Recent Studies (post-2010) (organophosphonates) | Studies (15-deoxyprostaglandin j2) | Trials (15-deoxyprostaglandin j2) | Recent Studies (post-2010) (15-deoxyprostaglandin j2) |
---|---|---|---|---|---|
9,968 | 880 | 3,596 | 379 | 2 | 145 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Authier, H; Auwerx, J; Balard, P; Benoit-Vical, F; Berry, A; Chambon, P; Coste, A; Desvergne, B; Lagane, C; Lepert, JC; Magnaval, JF; Metzger, D; Olagnier, D; Pipy, B; Séguéla, JP; Wahli, W | 1 |
1 other study(ies) available for organophosphonates and 15-deoxyprostaglandin j2
Article | Year |
---|---|
IL-13 induces expression of CD36 in human monocytes through PPARgamma activation.
Topics: Anilides; Animals; Arachidonic Acids; CD36 Antigens; Cell Line, Tumor; DNA; Enzyme Inhibitors; Erythrocytes; Gene Expression; Humans; Hypoglycemic Agents; Interleukin-13; Macrophages; Macrophages, Peritoneal; Mice; Monocytes; Organophosphonates; Phagocytosis; Phospholipases A; Phospholipases A2; Plasmodium falciparum; PPAR gamma; Prostaglandin D2; Protein Binding; Rosiglitazone; Thiazolidinediones; Transfection | 2007 |